13 research outputs found
Prospective Evaluation of Ultrasonic Surgical Dissectors in Hepatic Resection: A Cooperative Multicenter Study
Blood loss is the major cause of postoperative mortality and morbidity associated with hepatic resection.
A prospective multicenter study was conducted to determine if ultrasonic dissectors (USD) were useful
in hepatic resection and could reduce this hemorrhagic risk. Forty-seven hepatic resections were
performed in 42 consecutive patients during a two month period in 11 public, surgical centers.
Twenty-one patients had primary or secondary malignancies, six had benign tumors, two had biliary
cysts, one had cholangiocarcinoma, one had Caroli’s disease, and 11 had hydatid cysts of the liver. Two
different USD devices were evaluated (CUSA System-Lasersonics and NIIC-DX 101 T). The hepatic
resections tested included a wide range of procedures. Each surgeon had the possibility of choosing
between the USD and his own usual technique for each operative step and according to local conditions.
The average volume of blood infused, irrespective of the underlying pathology or the procedure
performed, was 1.0 L (range 0-4.8 L). Fourteen patients required no transfusions. No operative or
immediate postoperative deaths were recorded. Five major complications, all unrelated to the use of the
USD, developed in three patients. Access to intra and extraparenchymal arterial and venous tributaries
and particularly the control of the hepatic veins were facilitated by USD. While transection of hepatic
parenchyma was neither easier nor faster than with conventional techniques, it was found to be less
hemorrhagic. Overall appraisal was expressed on an analog scale; the USD was found to be helpful or
very helpful in 75 percent of all resections. With regard to the pathology being treated, total or partial
excision of hydatid cysts was greatly enhanced by the use of the USD while this benefit was not found for
wedge resections of other hepatic lesions. With regard to user friendliness and maintenance, the
NIIC-DX 101 T device was preferred. We conclude that the USD facilitates formal hepatic resections.
Converging opinions emerging from various surgical centers reinforce this conclusion
Successful Arterial Embolisation of Giant Liver Haemangioma
A 28-year old man presented with a symptomatic giant haemangioma. On June 26, 1983, at laparotomy,
no resection was attempted because the lesion involved the right lobe of the liver and a part of segments
II and III. The patient underwent a right hepatic arterial embolisation with gelatine sponge particles.
During follow-up, the patient remained asymptomatic. Five-year review by CT-scan showed a diminution
of the size of the haemangioma and hypertrophy of the left lobe. On October 21, 1988, the patient
was reoperated on for liver abscess and complete necrosis of the haemangioma. A right hepatectomy
was performed. In conclusion, the long-term effect of hepatic arterial embolisation, as demonstrated in
our case by regular CT-scans, is useful in cases of diffuse haemangioma as an alternative to hazardous
major liver resection. To our knowledge, the long-term effect of hepatic arterial embolisation on
symptoms and tumor size have never been reported for giant liver haemangioma
Prevention of intra-abdominal complications after pancreatic resection by octreotide. A prospective, multicenter, randomized trial
Safety and long-term outcome of a new concept for surgical adhesion-reduction strategies (Prevadh): a prospective, multicenter study.
International audienceBACKGROUND/AIMS: No agent has been consistently effective in preventing formation of peritoneal adhesions and postoperative bowel obstruction after abdominal surgery. The aim of this prospective multicenter study was to assess clinical safety and efficiency of a new adhesion-reduction barrier METHODOLOGY: Between September 2000 and April 2001, Prevadh was used in 78 patients. Operative procedures included 25 hepatic resections, 7 cholecystectomies, 32 colonic resections, 7 protectomies, 3 colostomy or recovery of continuity, 1 gynaecologic surgery and 3 others. Eleven patients were operated on by laparoscopy and 67 by laparotomy. RESULTS: The overall incidence of abscesses and wound complications was 2.4% and 9% respectively. After a mean follow-up of 36 months (range: 4-51 months), no patients experienced adverse events related to the adhesion barrier. Surgical reoperative procedures were performed in 10 patients for unrelated causes and no bowel obstruction occurred within the protected area. CONCLUSIONS: This study confirmed the safety of Prevadh adhesion barrier and suggested that this resorbable barrier might provide prevention from adhesion formation on peritoneal injured surfaces. However, a large randomized controlled trial remains necessary to prove the real effectiveness of adhesion barriers on clinical long-term outcome
Medial pancreatectomy: A multi-institutional retrospective study of 53 patients by the French Pancreas Club
Background. The results of medial pancreatectomy have been previously reported anecdotally. The purpose of the study was to provide short- and long-term results of ALP in a large multicenter collective series.
Methods. From 1990 to 1998, 53 patients (mean age +/- SD = 49 15 years) underwent medial pancreatectomy for primary cystic neoplasms of pancreas (n = 19), endocrine neoplasms (n = 17), intraductal papillary mucinous neoplasms (IPMN) (n = 6), fibrotic stenosis of the Wirsungs duct (n = 4), or other benign (n = 4) or malignant (n = 3) diseases. The proximal (right) pancreatic remnant was sutured (n = 53), and the distal (left) remnant was either anastomosed to a jejunal loop (n = 26), to the stomach (n = 25), or oversewn (n = 2). Medial pancreatectomy was indicated in 3 patients (6%) because of failed enucleation, in 3 (6%) to prevent worsening of preexisting diabetes, or to prevent de novo diabetes in a patient with chronic pancreatitis, and deliberately in the 4 7 others.
Results. The length of the resected pancreas was 5.0 +/- 2.2 cm (range, 2-15). One Patient (2%) died from a pancreatic fistula and portal thrombosis. Three patients were reoperated on because of complications related to the left pancreas, which was partially or totally resected. Pancreatic fistula developed in 16 patients (30%). Mean delay for the return of oralfeeding was related to the Presence of a pancreatic fistula. At follow-up (median = 26 months, range, 12-131), 1 pancreatic recurrence and 1 de novo diabetes occurred in patients without IPMN. In patients with IPMN, the rates of pancreatic recurrence and diabetes were 40% (215), respectively.
Conclusions. Medial pancreatectomy effectively preserves long-term endocrine function and is associated with a low risk of local recurrence, except in patients with IPMN. However, there is a high risk (30%) of PF after medial pancreatectomy